MultiHance® 9 Image Library 9 Seidl et al. 58F Metastatic Melanoma

MultiHance® (gadobenate dimeglumine) injection, 529 mg/mL vs. Gadavist® (gadobutrol)1

The MERIT Study
Seidl et al.
58-year-old woman with metastatic melanoma

These are representative images from reference studies; individual results may vary.
Reference: 1. Seidl Z, Vymazal J, Mechi M, et al. Does higher gadolinium concentration play a role in the morphologic assessment of brain tumors? Results of a multicenter intraindividual crossover comparison of gadobutrol versus gadobenate dimeglumine (the MERIT Study). AJNR Am J Neuroradiol. 2012;33(6):1050-1058.

More cases that may interest you